Defence Therapeutics Inc.
DTCFF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,193 | -$6,763 | -$7,344 | -$2,859 |
| Dep. & Amort. | $91 | $14 | $0 | $0 |
| Deferred Tax | $0 | -$105 | $0 | $0 |
| Stock-Based Comp. | $5,837 | $295 | $371 | $606 |
| Change in WC | $2,579 | -$1,362 | $928 | -$36 |
| Other Non-Cash | $398 | $708 | $327 | $678 |
| Operating Cash Flow | -$4,288 | -$7,657 | -$6,044 | -$2,290 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$203 | -$66 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$203 | -$66 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $27 | $2,355 | $0 | $0 |
| Stock Issued | $1,889 | $8,249 | $1,098 | $2,758 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$161 | -$594 | $0 | $3,119 |
| Financing Cash Flow | $1,755 | $10,009 | $1,098 | $5,877 |
| Forex Effect | $0 | -$2,284 | $0 | $0 |
| Net Chg. in Cash | -$2,736 | $2,286 | -$4,946 | $3,587 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,793 | $507 | $5,453 | $1,866 |
| End Cash | $57 | $2,793 | $507 | $5,453 |
| Free Cash Flow | -$4,492 | -$7,723 | -$6,044 | -$2,290 |